NewsAvi Kapoor
ICU Medical
ICUI · NASDAQ
$161.08−$0.16 (−0.10%)TodayMarket closed ·
Prev close $161.24
Latest news
- News
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate
- Press releaseGlobe Newswire
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
- Press releaseGlobe Newswire
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
- News
ICU Medical Q1 Adj. EPS $1.97 Beats $1.75 Estimate, Sales $530.200M Beat $520.483M Estimate
- Press releaseGlobe Newswire
ICU Medical Announces First Quarter 2026 Results
- Press releaseGlobe Newswire
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
- Press releasePRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
- Press releasePRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
- NewsEva Mathew
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks
- News
Insights into ICU Medical Q4 Earnings
- News
ICU Medical Q4 Adj. EPS $1.91 Beats $1.69 Estimate, Sales $540.704M Beat $530.633M Estimate
- Press releaseGlobe Newswire
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
- Press releaseGlobe Newswire
ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
- News
Earnings Scheduled For November 6, 2025
- NewsAvi Kapoor
This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- Press releaseGlobe Newswire
ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- News
Earnings Scheduled For May 8, 2025
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI
- Press releasePRNewswire
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
- Press releaseBusiness Wire
ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm
- Press releaseBusiness Wire
Securities Fraud Investigation Into ICU Medical, Inc. (ICUI) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
- Press releaseBusiness Wire
ICU Medical, Inc. (ICUI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Press releaseBusiness Wire
Securities Fraud Investigation Into ICU Medical, Inc. (ICUI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- Press releasePRNewswire
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps
- Press releasePRNewswire
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
- NewsVandana Singh
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death
- NewsVandana Singh
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.